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LETTERS TO THE EDITORReply to the Editor:
We thank Dr Durandy very much for
her comments. We completely agree
that performing transfusion-free sur-
gery cannot be a goal in itself. There
are convincing data from the adult
world and first data from the pediatric
world of cardiac surgery showing that
transfusion of allogeneic blood impairs
clinical outcomes. However, the small
scale of our investigation and the great
heterogeneity of cardiac malformations
meant that the studywas not powered to
perform an assessment in this regard.
As you outlined, in addition to the
technical aspects of the perfusion tech-
nique and the cardiopulmonary bypass
(CPB) setup, definition of the critical
hemoglobin value as a trigger for trans-
fusion remains a key question. As you
outlined, Jonas and coleagues1 re-
ported adverse neurological outcomes
in patients with a hematocrit level of
less than 20%, whereas a hematocrit
level of 24% was safe.2 In these pa-
tients surgical intervention was per-
formed during deep hypothermic
cardiac arrest or with low-flow CPB.
In our investigation only 6 patients un-
derwent deep hypothermia. However,
we performed regional arterial cerebral
perfusion and continuous measure-
ment of cerebral oxygenation using
near-infrared spectroscopy, which is
an established monitoring tool under
these circumstances.3,4 ThereforePEDIATRIC CARDIAC
SURGERY: EFFECT OF
A MINIATURIZED BYPASS
CIRCUIT IN REDUCING
HOMOLOGOUS BLOOD
TRANSFUSION
To the Editor:
I read with great interest the excel-
lent article by Koster and colleagues.1
We have recently published our expe-
rience in treating 150 pediatric patients
with a 120-mL prime volumeminiatur-
ized bypass circuit, vacuum-assisted
venous drainage, and intermittent
warm blood microplegia.2 Our results,
although less impressive than those of
Koster and colleagues,1 confirmed the
efficiency of a small prime volume
for reduction of allogeneic blood trans-
fusion. With a nadir hemoglobin value
of 8 g/dL during cardiopulmonary by-
pass, we demonstrated the good toler-
ance of hemodilution using 2
markers: preoperative and postopera-
tive lactate levels (which were lower
in patients undergoing bloodless sur-
gery than in transfused patients) and
time to extubation (which was shorter
in patients undergoing bloodless sur-
gery than in transfused patients). Our
major concern was to not counterbal-
ance the potential benefit of bloodless
surgery by altering the intraoperative
or postoperative care, thus inducing
other risks. We firmly believe that
transfusion cannot be the only out-
come end point in such a study group.
Pediatric perfusion is a challenging
technique with conflicting goals. The
benefit expected from reducing transfu-
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outcome at a lower cost.3 On the other
hand, a too low hematocrit level is haz-
ardous, and less than23.5% is said to be
associated with lower Psychomotor
Development Index scores and in-
creased lactate levels.4 In the literature
the need for somenorepinephrinebolus,
increased inotropic support, increased
ventilation time, and increased length
of critical care or hospitalization stay
have all been related to low periopera-
tive hematocrit levels.
In Koster and colleagues’ study
group,1 the factor triggering blood
transfusion during surgical intervention
was clearly a hemoglobin value of less
than 7 g/dL. However, the triggering
factor was less clear for the 4 patients
transfused during the further course.
The rationale to tolerate the same nadir
level of 7 g/dL of hemoglobin during
surgical intervention in patients with
large differences in preoperative hemo-
globin levels (from 11.1 g/dL [the low-
est level in the study] to 16.0 g/dL [the
highest level in the study]) is not obvi-
ous. Similarly, the technique used to
reverse the intraoperative anemia and
reach the postoperative hemoglobin tar-
get values, namely 8 to 10 g/dL in pa-
tients with anatomic correction and 12
to 16 g/dL in cyanotic patients with pal-
liative procedures, is unclear.
Even if 85% of the patients were fi-
nally transfused, Koster and col-
leagues1 are to be congratulated for
their energy in promoting bloodless
neonatal surgery. The efficiency of
the miniaturized bypass circuit in re-
ducing blood transfusion is well estab-
lished. However, the link between
bloodless surgery and improved im-
mediate clinical outcome has yet to
be confirmed, as has its lack of harm
on late neurological outcome.
Yves Dominique Durandy, MD
Intensive Care Unit
Institut Jacques Cattier
Massy, France
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